TranS1, which develops and designs devices for degenerative lower lumber spine conditions, admits no wrongdoing as part of the settlement, according to the report.
The settlement should be finalized within the next few months.
More Articles on Devices:
Life Spine Releases Lateral Retractor, Spacer Devices
NUI Galway Plans Release of OsteoAnchor Joint Technology
Drug-Device Combination Market to Reach $30.5B by 2017
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
